Article

Patients with RA have high familial risk of other autoimmune diseases

There is extensive genetic sharing between rheumatoid arthritis (RA) and other autoimmune and associated diseases. Such sharing is evidenced by high familial risks of discordant autoimmune diseases in parents and offspring, singleton siblings, twins, and spouses.

There is extensive genetic sharing between rheumatoid arthritis (RA) and other autoimmune and associated diseases. Such sharing is evidenced by high familial risks of discordant autoimmune diseases in parents and offspring, singleton siblings, twins, and spouses.

Hemminki and associates used data from 47,361 patients with RA and their family members to estimate associations of RA with any of 33 autoimmune diseases and related conditions. Standardized incidence ratios (SIRs) were calculated, and familial risks were determined for male and female patients with relatives who had concordant or discordant autoimmune diseases.

The SIR for RA in offspring of affected parents was 3.02. The significant SIRs for RA in offspring according to parental proband were ankylosing spondylitis, 2.96; localized scleroderma, 2.40; Sjgren syndrome, 2.25; systemic lupus erythematosus, 2.13; systemic sclerosis, 1.65; Hashimoto thyroiditis/hypothyroidism, 1.54; pernicious anemia, 1.53; sarcoidosis, 1.40; psoriasis, 1.36; Wegener granulomatosis, 1.34; and asthma or polymyalgia rheumatica, 1.32. Other SIRs for RA were 4.64 in siblings, 9.31 in multiplex families, 6.48 in twins, and 1.17 in spouses.

The authors noted that this study was the first to compare the familial risks of RA in relation to a large number of autoimmune diseases and related conditions using data from a single population.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.